Back to top

Kepler Capital Remains a Hold on Novonesis (0Q4U)

In a report released on June 25, Patrick Roquas from Kepler Capital maintained a Hold rating on Novonesis (0Q4U – Research Report), with a price ta...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novozymes A/S (NVZMY)